Redmile Group, LLC 13D and 13G filings for IGM Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-15 5:01 pm Sale | 2025-08-14 | 13D | IGM Biosciences, Inc. IGMS | Redmile Group, LLC | 0 0.000% | -3,291,092 (Position Closed) | Filing |
| 2023-06-28 5:15 pm Purchase | 2023-06-26 | 13D | IGM Biosciences, Inc. IGMS | Redmile Group, LLC | 3,291,092 9.900% | 257,595 (+8.49%) | Filing |
| 2023-06-13 5:15 pm Sale | 2023-06-12 | 13D | IGM Biosciences, Inc. IGMS | Redmile Group, LLC | 3,033,497 10.300% | -343,593 (-10.17%) | Filing |
| 2022-10-05 5:00 pm Purchase | 2022-10-03 | 13D | IGM Biosciences, Inc. IGMS | Redmile Group, LLC | 3,377,090 11.600% | 14,630 (+0.44%) | Filing |
| 2022-04-05 5:09 pm Sale | 2022-04-01 | 13D | IGM Biosciences, Inc. IGMS | Redmile Group, LLC | 3,362,460 12.900% | -75,572 (-2.20%) | Filing |